节点文献

莲子心新碱对转化生长因子β1诱导的H1299细胞侵袭和迁移的抑制作用及其机制

Study on Effect and Mechanism of Neoliensine on Invasion and Migration of H1299 Cells Induced by TGF-β1

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 张婉婷王歆竹米玉辉杨光明潘扬

【Author】 ZHANG Wanting;WANG Xinzhu;MI Yuhui;YANG Guangming;PAN Yang;College of Pharmacy,Nanjing University of Chinese Medicine;Key Laboratory of State Administration of Traditional Chinese Medicine for Standardization of Chinese Medicine Processing & Jiangsu Key Laboratory of Chinese Medicine Processing;Laboratory of Medical Fungi and Phyto-Biotech,Nanjing University of Chinese Medicine;

【通讯作者】 杨光明;潘扬;

【机构】 南京中医药大学药学院江苏省中药炮制重点实验室国家中医药管理局中药炮制标准重点研究室南京中医药大学药用菌与中药生物技术研究所

【摘要】 目的构建转化生长因子β1(TGF-β1)诱导的人非小细胞肺癌(Non-small cell lung cancer,NSCLC)H1299细胞上皮-间充质转化(EMT)模型,并探讨莲子心新碱(Neoliensine,NeoL)对其侵袭和迁移能力的抑制作用及潜在机制。方法用5、10、15 ng·mL-1的TGF-β1诱导H1299细胞构建EMT模型;以15 ng·mL-1的TGF-β1诱导H1299细胞作为EMT模型组,以法舒地尔(Fas)为阳性药,设置1、2、3μmol·L-1的莲子心新碱实验组。采用倒置荧光显微镜观察诱导后的细胞形态;用CCK-8法检测莲子心新碱对H1299细胞的抑制率;Western Blot法检测细胞黏附因子E-钙黏蛋白(E-cadherin)以及间充质标记物N-钙黏蛋白(N-cadherin)、波形蛋白(Vimentin)以及ROCK 1与P-Smad 2/3蛋白的表达;Transwell法检测莲子心新碱对TGF-β1诱导的H1299细胞侵袭、迁移的抑制作用;免疫荧光法检测H1299细胞内ROCK 1蛋白的表达及分布。结果 TGF-β1诱导后H1299细胞形态呈现间充质特性。与对照组比较,随着TGF-β1浓度的升高,E-cadherin表达明显降低(P<0.05,P<0.01),N-cadherin与Vimentin表达明显升高(P<0.01,P<0.001),并且ROCK 1蛋白的表达也在这一过程中升高(P <0.05)。莲子心新碱可以抑制H1299细胞的活力,IC50为5.04μmol·L-1;同时与模型组比较,莲子心新碱抑制了TGF-β1促进的H1299细胞EMT过程及侵袭迁移作用(P<0.001),中、高剂量组明显增加E-cadherin蛋白的表达(P<0.05),明显减少N-cadherin和Vimentin蛋白的表达(P<0.001),还明显降低了H1299细胞内因TGF-β1诱导而升高的ROCK 1(P<0.001)和P-Smad2/3(P<0.001)蛋白的水平。免疫荧光结果显示莲子心新碱可以抑制TGF-β1诱导的H1299细胞胞质中ROCK 1蛋白的表达及分布。结论 TGF-β1可以诱导H1299细胞发生EMT,莲子心新碱可以有效抑制这一过程,其机制可能是抑制了TGF-β1/Smad/RhoA/ROCK通路。

【Abstract】 Objective To build a TGF-β1 induced epithelial-mesenchymal transition(EMT)model of non-small cell lung cancer(NSCLC)H1299 cells and explore the inhibitory effect and potential mechanism of neoliensine(NeoL)on the invasion and migration of the EMT model cells.Methods H1299 cells were induced by different concentrations(5, 10, 15 ng · mL-1) of TGF-β1 to construct EMT model. In NeoL intervention experiment,15 ng·mL-1 of TGF-β1-induced H1299 cells were used as the EMT model group,fasudil(Fas)was used as the positive control medicine,and experimental groups were treated with 1,2 and 3 μmol·L-1 of NeoL. The morphology changes of TGF-β1-induced H1299 cells were observed by inverted fluorescence microscope. CCK-8 assay was used to determine the inhibitory rate of NeoL on H1299 cells. The expressions of adhesion factor E-cadherin,mesenchymal markers N-cadherin,vimentin,ROCK 1 and P-Smad 2/3 in NeoL treated cells were detected by Western Blot(WB). Transwell assay was operated to figure out the inhibitory effect of NeoL on invasion and migration of TGF-β1-induced H1299 cells. And immunofluorescence assay was used to detect the expression and distribution of ROCK 1 in H1299 cells.Results After TGF-β1 induction, H1299 cells showed characteristic of mesenchymal morphology. Compared with the control group,the expression of reduced E-cadherin(P < 0.05,P <0.01)and high N-cadherin and increased vimentin(P < 0.01,P < 0.001)significantly correlated with the increase of TGF-β1. Meanwhile,the expression of ROCK 1 also increased(P < 0.05). NeoL suppressed the vitality of H1299 cells,and the IC50 value was 5.04 μmol·L-1. Compared with the model group,NeoL could inhibit TGF-β1 induced EMT in H1299 cells,invasion and migration(P < 0.001). NeoL intervention significantly increased the expression of E-cadherin proteins(P < 0.05). The TGF-β1-induced increase of ROCK 1 and P-Smad2/3 proteins in H1299 cells also significantly reduced(P < 0.001). The results of immunofluorescence showed that NeoL inhibited the expression and distribution of ROCK 1 protein in the cytoplasm of the TGF-β1-induced H1299 cells.Conclusion TGF-β1 can induce EMT of H1299 cells. NeoL can effectively inhibit this process possibly by inhibiting the TGF-β1/Smad/RhoA/ROCK pathway.

【关键词】 莲子心新碱(NeoL)H1299细胞TGF-β1ROCK 1侵袭迁移
【Key words】 Neoliensine(NeoL)H1299 cellsTGF-β1ROCK 1invasionmigration
【基金】 国家自然科学基金项目(81373295)
  • 【文献出处】 中药新药与临床药理 ,Traditional Chinese Drug Research and Clinical Pharmacology , 编辑部邮箱 ,2021年10期
  • 【分类号】R285.5
  • 【被引频次】1
  • 【下载频次】272
节点文献中: 

本文链接的文献网络图示:

本文的引文网络